PMC:7784830 / 2480-2706
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 46 | 148-169 | Chemical | denotes | chloroquine phosphate | MESH:C023676 |
| 47 | 173-199 | Chemical | denotes | hydroxychloroquine sulfate | MESH:D006886 |
| 54 | 213-221 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 0-226 | Sentence | denotes | Followed by this development, emergency use authorization was granted by United States Food and Drug Administration (USFDA) to promote the usage of chloroquine phosphate or hydroxychloroquine sulfate for treating COVID-19 [7]. |